Speaker illustration

Doctor Nicholas Chew

National University Health System, Singapore (Singapore)

Member of:

European Society of Cardiology

Dr Nicholas Chew is a Cardiology senior resident at the National University Heart Centre Singapore with research interests focused on exploring non-standard cardiovascular risk factors in coronary artery disease and cardiometabolic diseases. He is the Principle Investigator in studies exploring the cardiovascular manifestations of fatty liver. He holds several grants and serves as the Guest Editor on Frontiers in Medicine and Cells focusing on the heart-liver axis. He is a Young Investigator’s Award winner on his work regarding fatty liver disease and acute myocardial infarction. He is a strong believer in the ABCs of research - always be collaborative!

The global syndemic of metabolic diseases in the young adult population: a consortium from the Global Burden of Disease 2000-2019

Event: ESC Asia 2022 with APSC & AFC

Topic: Public Health

Session: Risk Factors and Prevention

Thumbnail

Global burden of metabolic diseases: data from Global Burden of Disease 2000-2019. A cosortium of metabolic disease

Event: ESC Asia 2022 with APSC & AFC

Topic: Public Health

Session: Poster Session 2

Thumbnail

Metabolic associated fatty liver disease increases risk of adverse events after acute coronary syndrome.

Event: ESC Congress 2022

Topic: Clinical

Session: What defines risk in acute coronary syndromes

Thumbnail

Comparison of mechanistic pathways of metabolic bariatric surgery in diabetic patients

Event: ESC Congress 2022

Topic: Diabetes and the Heart

Session: Diabetes and the Heart 3

Thumbnail

Reconstructed meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting for left main disease

Event: ESC Congress 2022

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: All about coronary artery disease

Thumbnail

Prognostically distinct phenotypes of metabolic health beyond obesity in aortic stenosis

Event: ESC Congress 2022

Topic: Aortic Valve Stenosis

Session: Predictors of severity in asymptomatic valvular disease

Thumbnail

Coronary artery bypass grafting versus percutaneous coronary intervention with stenting for multivessel coronary artery disease without left main coronary disease:reconstructed individual patient data

Event: ESC Congress 2022

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Coronary artery disease, acute coronary syndromes and more

Thumbnail

A 10-year cohort on prognostic outcomes in patients presenting with acute myocardial infarction complicated by cardiogenic shock and/or cardiac arrest

Event: ESC Congress 2022

Topic: Cardiogenic Shock

Session: Cardiac arrest and acute coronary syndrome

Thumbnail

The prognostic outcomes of acute myocardial infarction stratified according to metabolic health and obesity status

Event: ESC Congress 2022

Topic: Clinical

Session: Risks for acute coronary syndromes

Thumbnail

Higher long-term mortality in patients with concomitant acute coronary syndrome and aortic stenosis

Event: ESC Congress 2022

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Approach to acute coronary syndromes

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb